We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+7.18%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
AUM
$7.62B
AUM Growth
+$501M
Cap. Flow
-$682M
Cap. Flow %
-8.96%
Top 10 Hldgs %
31.49%
Holding
3,289
New
550
Increased
1,163
Reduced
866
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 12.31%
2 Financials 6.67%
3 Industrials 4.87%
4 Consumer Discretionary 3.57%
5 Healthcare 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCK icon
876
Crown Holdings
CCK
$12.8B
$205K ﹤0.01%
2,118
+610
+40% +$61.2K
RMD icon
877
ResMed
RMD
$28.3B
$203K ﹤0.01%
742
+96
+15% +$26.2K
NEAR icon
878
iShares Short Maturity Bond ETF
NEAR
$4.8B
$202K ﹤0.01%
3,948
FAB icon
879
First Trust Multi Cap Value AlphaDEX Fund
FAB
$152M
$202K ﹤0.01%
+2,317
New +$198K
MPLX icon
880
MPLX
MPLX
$59.5B
$202K ﹤0.01%
4,038
+8
+0.2% +$406
NTSX icon
881
WisdomTree US Efficient Core Fund
NTSX
$1.34B
$200K ﹤0.01%
+3,714
New +$192K
EIM
882
Eaton Vance Municipal Bond Fund
EIM
$492M
$199K ﹤0.01%
20,000
BNY
883
Bank of New York Mellon
BNY
$108B
$199K ﹤0.01%
1,823
-2,138
-54% -$218K
HIO
884
Western Asset High Income Opportunity Fund
HIO
$335M
$199K ﹤0.01%
51,699
-15,869
-23% -$63K
AWI icon
885
Armstrong World Industries
AWI
$6.86B
$198K ﹤0.01%
1,012
+110
+12% +$20.5K
AUTL
886
Autolus Therapeutics
AUTL
$386M
$197K ﹤0.01%
121,107
NTNX icon
887
Nutanix
NTNX
$14.9B
$196K ﹤0.01%
2,638
+1,108
+72% +$81.3K
HLIO icon
888
Helios Technologies
HLIO
$2.64B
$196K ﹤0.01%
3,756
+6
+0.2% +$280
EL icon
889
Estee Lauder
EL
$29B
$193K ﹤0.01%
2,192
-1,800
-45% -$160K
CMS icon
890
CMS Energy
CMS
$23.1B
$193K ﹤0.01%
2,633
-99
-4% -$7.11K
EMB icon
891
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$193K ﹤0.01%
2,025
-463
-19% -$43.4K
XLB icon
892
State Street Materials Select Sector SPDR ETF
XLB
$8.51B
$190K ﹤0.01%
4,250
-922
-18% -$41.7K
EXAS
893
DELISTED
Exact Sciences
EXAS
$190K ﹤0.01%
3,472
+365
+12% +$18.2K
XMMO icon
894
Invesco S&P MidCap Momentum ETF
XMMO
$7.39B
$189K ﹤0.01%
1,400
BMRN icon
895
BioMarin Pharmaceuticals
BMRN
$11.5B
$187K ﹤0.01%
3,454
+1,304
+61% +$74.6K
SUN icon
896
Sunoco
SUN
$14.2B
$187K ﹤0.01%
3,736
HUM icon
897
Humana
HUM
$46.7B
$187K ﹤0.01%
718
+75
+12% +$19.7K
IFF icon
898
International Flavors & Fragrances
IFF
$19.4B
$186K ﹤0.01%
3,021
+173
+6% +$11.9K
NBIX icon
899
Neurocrine Biosciences
NBIX
$17.7B
$184K ﹤0.01%
1,314
+582
+80% +$78.9K
MET icon
900
MetLife
MET
$61B
$183K ﹤0.01%
2,216
-178
-7% -$14K

Similar funds

Clearstead Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Clearstead Advisors held 3,289 positions worth $7.62B, up 7% from $7.12B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Clearstead Advisors withdrew a net $682M in Q3 2025, closing 207 positions and reducing 866 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $694M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.

Against the trend, Clearstead Advisors opened a new position in Invesco BulletShares 2033 Corporate Bond ETF worth $20.4M.

  • Clearstead Advisors's largest Q3 2025 buy was Invesco BulletShares 2033 Corporate Bond ETF: 949,887 shares worth $20.4M.
  • Clearstead Advisors added most to iShares Core MSCI Total International Stock ETF in Q3 2025, an estimated $22.8M increase.
  • Clearstead Advisors's biggest Q3 2025 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $21.4M.
  • Clearstead Advisors fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $694M.
  • Clearstead Advisors's ten largest holdings make up 31% of its $7.62B portfolio in Q3 2025.
  • Clearstead Advisors opened 550 new positions and closed 207 in Q3 2025.
  • Clearstead Advisors's portfolio value rose 7% quarter-over-quarter to $7.62B.

Based on Clearstead Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.